ストックスクリーナーアプリを入手
5.34
0.37%
-0.02
アフターアワーズ：
5.32
-0.02
-0.37%
前日終値:
$5.36
開ける：
$5.36
24時間の取引高:
586.75K
Relative Volume:
1.16
時価総額：
$1.20B
収益：
$596.48M
当期純損益:
$123.72M
株価収益率:
9.7374
EPS:
0.5484
ネットキャッシュフロー:
$106.59M
1週間 パフォーマンス:
-0.37%
1か月 パフォーマンス:
-0.93%
6か月 パフォーマンス:
+50.42%
1年 パフォーマンス:
+94.89%
1日の値動き範囲:
$5.34
$5.36
1週間の範囲:
$5.33
$5.38
52週間の値動き範囲:
$2.37
$5.72
Curevac N V Stock (CVAC) Company Profile
CVAC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
5.34 | 1.21B | 596.48M | 123.72M | 106.59M | 0.5484 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-13 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-25 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-06-08 | 開始されました | SVB Securities | Outperform |
| 2023-01-19 | アップグレード | UBS | Neutral → Buy |
| 2023-01-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-01-21 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-01-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-10-22 | 開始されました | Deutsche Bank | Hold |
| 2021-06-17 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Underperform |
| 2021-04-26 | 開始されました | Guggenheim | Neutral |
| 2020-12-10 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2020-09-08 | 開始されました | BofA Securities | Buy |
| 2020-09-08 | 開始されました | Credit Suisse | Neutral |
| 2020-09-08 | 開始されました | Jefferies | Hold |
すべてを表示
Curevac N V (CVAC) 最新ニュース
Will CureVac N.V. stock benefit from green energy trendsJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Why CureVac N.V. stock is a value investor pickWeekly Trend Report & Verified Technical Trade Signals - newser.com
How interest rate cuts could boost CureVac N.V. stock2025 Price Targets & Verified Chart Pattern Signals - newser.com
Can CureVac N.V. stock resist market sell offsRisk Management & Technical Confirmation Alerts - newser.com
Smart tools for monitoring CureVac N.V.’s price actionQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Using data tools to time your CureVac N.V. exitJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
How currency fluctuations impact CureVac N.V. stock2025 AllTime Highs & Free Reliable Trade Execution Plans - newser.com
Is CureVac N.V. stock positioned for digital transformation2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Historical volatility pattern of CureVac N.V. visualized2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
CureVac N.V. (NASDAQ:CVAC) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Analyzing net buyer seller activity in CureVac N.V.Options Play & Precise Trade Entry Recommendations - newser.com
Is CureVac N.V. stock ready for breakoutMarket Activity Report & Risk Controlled Swing Trade Alerts - Fundação Cultural do Pará
CureVac’s New mRNA Study: A Potential Game-Changer in Lung Cancer Treatment - TipRanks
CureVac schedules extraordinary shareholder meeting for November 25 By Investing.com - Investing.com South Africa
CureVac Announces Extraordinary Meeting for Merger with BioNTech - TipRanks
CureVac schedules extraordinary shareholder meeting for November 25 - Investing.com
Curevac N V (CVAC) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):